you are viewing a single comment's thread.
Wedbush just issued report - unchanged at outperform at $38 in a year. This is nuts. I am adding. However, it does hurt to see it down in this territory not since Spring 2009 pre ASCO.
Todays action a speed bump in the road. But 427 has just taken on a more significant value adding relevance for a 2012 stock pop.box